Tam KY

References (3)

Title : Evaluations of the neuroprotective effects of a dual-target isoquinoline inhibitor in the triple transgenic mouse model of Alzheimer's disease - Wei_2023_Neurosci.Lett_802_137166
Author(s) : Wei R , He JQ , Chen WH , Tam KY
Ref : Neuroscience Letters , 802 :137166 , 2023
Abstract : Wei_2023_Neurosci.Lett_802_137166
ESTHER : Wei_2023_Neurosci.Lett_802_137166
PubMedSearch : Wei_2023_Neurosci.Lett_802_137166
PubMedID: 36889377

Title : Dual targeting of cholinesterase and amyloid beta with pyridinium\/isoquinolium derivatives - Chakravarty_2020_Drug.Dev.Res_81_242
Author(s) : Chakravarty H , Ju Y , Chen WH , Tam KY
Ref : Drug Dev Res , 81 :242 , 2020
Abstract : Chakravarty_2020_Drug.Dev.Res_81_242
ESTHER : Chakravarty_2020_Drug.Dev.Res_81_242
PubMedSearch : Chakravarty_2020_Drug.Dev.Res_81_242
PubMedID: 31837041

Title : An Isoquinolinium Dual Inhibitor of Cholinesterases and Amyloid beta Aggregation Mitigates Neuropathological Changes in a Triple-Transgenic Mouse Model of Alzheimer's Disease - Ju_2020_ACS.Chem.Neurosci_11_3346
Author(s) : Ju Y , Chakravarty H , Tam KY
Ref : ACS Chem Neurosci , 11 :3346 , 2020
Abstract : Ju_2020_ACS.Chem.Neurosci_11_3346
ESTHER : Ju_2020_ACS.Chem.Neurosci_11_3346
PubMedSearch : Ju_2020_ACS.Chem.Neurosci_11_3346
PubMedID: 33001625